(Q33868508)

29 July 2017

title

Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma (English)

1 reference

29 July 2017

0 references

0 references

hepatocellular carcinoma

1 reference

9

Giuseppe Montalto

1 reference

29 July 2017

7

Melchiorre Cervello

1 reference

29 July 2017

8

Natale D'Alessandro

1 reference

29 July 2017

2

Lydia Giannitrapani

1 reference

29 July 2017

Maurizio Soresi

1

1 reference

29 July 2017

Fabio D'Antona

3

1 reference

29 July 2017

Ada-Maria Florena

4

1 reference

29 July 2017

Emanuele La Spada

5

1 reference

29 July 2017

Angela Terranova

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

World Journal of Gastroenterology

29 July 2017

published in

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

16

1 reference

29 July 2017

page(s)

2563-2568

1 reference

Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotides

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Serum levels of interleukin 6 in patients with lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin-6 family of cytokines and gp130

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Molecular regulation of B lymphocyte response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Human soluble IL-6 receptor: its detection and enhanced release by HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin-6 in renal cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Interleukin-6 production by human melanoma cell lines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087989

Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine?

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V12.I16.2563

Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study

21 January 2018

1 reference

12 December 2020

Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

The influence of interleukin-6 on the growth of human esophageal cancer cell lines

1 reference

12 December 2020

Elevated serum interleukin-6 levels in patients with acute hepatitis

1 reference

12 December 2020

Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma

1 reference

12 December 2020

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production

1 reference

12 December 2020

Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

1 reference

12 December 2020

[Role of interleukin 6 in hepatocellular carcinoma]

1 reference

12 December 2020

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Serum interleukin-6 levels reflect disease status of gastric cancer

1 reference

12 December 2020

Interleukin-6 activity in urine and serum in patients with bladder carcinoma

1 reference

12 December 2020

Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis

1 reference

12 December 2020

Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I16.2563

1 reference

29 July 2017

1 reference

29 July 2017

1 reference